FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Albuterol Sulfate and Ipratropium Bromide Inhalation Solution
Status: Discontinuation
»Therapeutic Categories: Pulmonary/Allergy

Teva Pharmaceuticals (New 07/03/2019)

Company Contact Information:

Presentation Posting Date Related Information
0.3 mg mg/3 mL and 0.5 mg/3 mL (NDC 0591-3817-39) 07/03/2019 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English